Connect with us

Hi, what are you looking for?

Trade Strategy LabTrade Strategy Lab

World News

Omaha city councilman mounts bid to succeed outgoing House Republican Rep. Don Bacon

Omaha City Councilman Brinker Harding has launched a bid to succeed outgoing U.S. Rep. Don Bacon, R-Neb., who announced that he will not seek re-election next year.

‘I’m a husband, father, businessman, and Omaha City Councilman. Today, I am announcing my run for Congress in NE-02 to make America more like its Heartland and to make the next 250 years a New Golden Age for America. I hope you’ll join me!’ Harding declared in a July 1 post on X.

Bacon, who has served in Congress since 2017, has announced that he will finish his current term, but will not run for re-election in 2026.

‘Thank you, @DonJBacon, for your 30 years of distinguished service in the Air Force and a decade of dedicated leadership representing NE-02 in Congress,’ Harding declared in a June 30 post on X. ‘You’ve been a true statesman who’s served with integrity and heart. Wishing you and Angie all the best in this next chapter.’

While Republicans have been divided on the issue, Bacon is a staunch proponent of U.S. aid to Ukraine.

‘It is a time for honesty. Peace talks are having zero effect on Putin. His goal is to dominate Ukraine & he won’t stop until he realizes he cannot win. The U.S. & Allies must arm Ukraine to the teeth, sanction Russia to the max, & confiscate the $300B in overseas Russian assets,’ the congressman declared in a post on X in late May.

U.S. Sen. Deb Fischer, R-Neb., is backing Harding for the House seat.

‘Throughout a lifetime of service to Omaha and Nebraska, Brinker Harding has always championed public safety, economic development, and fiscal responsibility. Brinker will make America safer, stronger, and more prosperous. I am honored to endorse him for Congress,’ Fischer noted in a post on X.

This post appeared first on FOX NEWS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Investing

Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...

Business

A nationwide coordinated crackdown on retail crime — what authorities are calling the first of its kind — led to hundreds of arrests in...

Investing

Phase 1 1 First-In-Human study designed to assess safety   ,   tolerability   , right dose for Phase 2 and early signs of...

Stock

Over the past five sessions, the Indian equity markets headed nowhere and continued consolidating in a defined range. In the previous weekly note, it...